FDA OKs New Epilepsy Drug

Saturday, 09 Nov 2013 09:39 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. health regulators on Friday approved a new drug made by Sunovion Pharmaceuticals, a U.S.-based unit of Japanese drugmaker Dainippon Sumitomo Pharma Co, as an add-on medicine to reduce seizures associated with epilepsy.

The drug, to be sold under the brand name Aptiom and known chemically as eslicarbazepine, significantly reduced the frequency of epileptic seizures compared with a placebo in clinical trials.

"Some patients with epilepsy do not achieve satisfactory seizure control from existing treatments," Eric Bastings, acting director of the FDA's Division of Neurology Products, said in a statement. "It is important we continue to make new treatment options available to patients.
 
Like other antiepileptic drugs, Aptiom may cause suicidal thoughts or actions in a very small number of people, the Food and Drug Administration cautioned in its approval announcement.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Comments
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Find Your Condition
You May Also Like
Around the Web
Most Commented

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

NEWSMAXHEALTH.COM
© Newsmax Media, Inc.
All Rights Reserved